L-Carnitine

L-Carnitine is an amino-acid-derived compound studied for mitochondrial fat transport, energy metabolism, and body-composition support, with subcutaneous use favored in the source to bypass oral TMAO production.

Profile · 01

Overview

L-Carnitine is a quaternary ammonium compound synthesized from lysine and methionine that helps shuttle long-chain fatty acids into mitochondria for beta-oxidation. Unlike many pages in this library, it is an endogenous nutrient derivative with established biochemistry and an FDA-approved injectable form for specific deficiency states.

The source emphasizes why researchers may prefer parenteral use over oral use: oral bioavailability is limited, and some unabsorbed carnitine can be converted by gut bacteria into TMA and then TMAO. This page summarizes the once-daily subcutaneous protocol provided in the source markdown.

At a Glance

Goal
Support mitochondrial fatty-acid oxidation, energy production, and body-composition goals while avoiding oral TMAO formation
Categories
Fat MetabolismEnergyBody CompositionMitochondrial Support
Synergistic
CoQ10 · Alpha-lipoic acid · Acetyl-L-carnitine · Omega-3 fatty acids
Profile · 02

Protocol

Suggested once-daily titration approach starting at half dose for the first two weeks.

Reconstitute
Add 2.0 mL bacteriostatic water to a 200 mg vial for 100 mg/mL concentration
Typical daily range
50-100 mg once daily; some advanced protocols discuss up to 200 mg
Start
50 mg daily for Weeks 1-2
Target
100 mg daily from Week 3 onward
Frequency
Once daily (subcutaneous)
Cycle Length
8-12 weeks with optional extension to 16 weeks
Timing
Morning or pre-exercise is common; use any consistent time and rotate sites
Route
Subcutaneous
Cycle
8-12 weeks on, 4 weeks off

Inject once daily subcutaneously. At the source concentration, each unit on a U-100 insulin syringe equals 1 mg, which makes dose math unusually simple. The source frames the main advantage of this route as direct systemic delivery without the gut-bacterial TMAO pathway associated with oral use.

Dose progression

Weeks 1-2
50 mg · 50 units (0.50 mL)
Weeks 3-8
100 mg · 100 units (1.00 mL)
Weeks 9-12
100 mg · 100 units (1.00 mL)

Important: This guide is for educational purposes only and is not medical advice. For research use only. Not for human consumption.

Science · 01

How L-Carnitine works.

L-Carnitine acts as an obligate cofactor for the carnitine palmitoyltransferase system that moves long-chain fatty acids across the inner mitochondrial membrane for beta-oxidation. That makes it central to ATP production from fat stores, especially during endurance work or caloric restriction.

The source highlights a route-of-administration distinction rather than a novel mechanism. Oral L-carnitine has incomplete bioavailability and can increase gut-derived TMAO production, while subcutaneous or intravenous use bypasses that pathway entirely. Clinical literature is strongest in deficiency states, dialysis populations, and broader metabolic-support discussions.

Science · 02

Effects

Observations from clinical or preclinical literature.

Supports mitochondrial fatty-acid transport and ATP production from lipid stores
May support body-composition and fatigue-related goals in some clinical settings
Parenteral use avoids the oral gut-bacterial TMAO pathway emphasized in the source
Clinical use in deficiency and dialysis populations suggests generally good tolerability
Mild injection-site irritation may occur
Long-term subcutaneous protocol data for body-composition use remain limited
Science · 03

Caution

Use caution in seizure disorders because some carnitine-related products have been linked to lowered seizure threshold
Not recommended during pregnancy or breastfeeding without qualified medical supervision
Use caution with anticoagulants such as warfarin
Monitor thyroid status if using higher doses because carnitine may influence thyroid-hormone activity

Important: This guide is for educational purposes only and is not medical advice. For research use only. Not for human consumption.

Lifestyle · 01

CoFactors

CoQ10
Supports the mitochondrial electron-transport chain alongside fatty-acid delivery.
Alpha-lipoic acid
Supports mitochondrial energy metabolism and antioxidant defense.
B vitamins
Help support beta-oxidation and broader energy-metabolism pathways.
Iron
Required for endogenous carnitine synthesis.
Vitamin C
Supports endogenous carnitine synthesis from lysine and methionine.
Lifestyle · 02

Life Factors

Complementary strategies for best outcomes.

Pair with resistance training and aerobic work to reinforce fat-oxidation and performance goals
Use a protein-adequate diet with sufficient lysine and methionine intake
Maintain a modest caloric deficit if fat loss is the goal
Prioritize sleep, hydration, and recovery because mitochondrial support is not a substitute for basics
Lifestyle · 03

Metrics

Day-to-day metrics worth tracking through the protocol.

  1. Body composition - monitor weight, body-fat trends, and lean-mass preservation
  2. Exercise performance and energy - useful for tracking endurance or recovery changes
  3. Fatigue levels - may reflect changes in energy metabolism or overall recovery
  4. Injection-site reactions - note redness, swelling, or discomfort
Lifestyle · 04

Labs

Baseline and periodic bloodwork to monitor systemic health during the protocol.

Free and total carnitine
Helps assess baseline carnitine status and response to repletion.
Acylcarnitine profile
Provides more detailed context on fatty-acid oxidation.
TMAO
Optional specialized marker if route-of-administration comparison is a research interest.
Lipid panel
Useful for broader cardiovascular and metabolic context.
CMP (Comprehensive Metabolic Panel)
Assesses liver and kidney function during the protocol.
Thyroid panel
Reasonable to monitor when using higher doses or in thyroid-sensitive individuals.
Calculators · 01

Supplies Calculator

Estimates assume the schedule defined for this peptide.

Length
Vial size
Bac. water
Syringe
Vials
0 × 200 mg each…
Syringes
0
Bac. water
0 mL
Swabs
02 per syringe
Calculators · 02

Dose Calculator

Dose Calculator

Vial
Bac. water
Syringe
Dose
Concentration
0mg/mL
Volume per dose
0mL
…
Practice · 01

Preparation

Careful technique preserves potency. Solution should be clear — do not shake.

  1. Allow vial to reach room temperature for 15–20 minutes before reconstitution.
  2. Draw the chosen bacteriostatic water volume with a sterile syringe.
  3. Inject slowly down vial wall; avoid foaming.
  4. Gently swirl/roll until dissolved (do not shake).
  5. Label with reconstitution date and refrigerate at 2–8 °C (35.6–46.4 °F), protected from light.
  6. Use within 30 days; discard any unused solution after 30 days.
Practice · 02

Technique

General subcutaneous guidance from clinical best-practice resources.

Clean the vial stopper and injection site with alcohol and allow them to dry fully
Pinch a skinfold and insert the needle at 45-90 degrees into subcutaneous tissue
Do not aspirate for subcutaneous injections; inject slowly and steadily
Wait a few seconds before withdrawing the needle to reduce leakage at larger volumes
Rotate sites across the abdomen, thighs, and upper arms and discard used syringes in a sharps container

Important: This guide is for educational purposes only and is not medical advice. For research use only. Not for human consumption.

Practice · 03

Storage

Lyophilized
Store at room temp in dry, dark conditions; minimize moisture exposure.
Reconstituted
Refrigerate at 2–8 °C (35.6–46.4 °F); avoid freeze–thaw cycles. Discard reconstituted vials after 30 days.

Notes

Allow vials to reach room temperature before opening to reduce condensation uptake.
Reference · 01

Notes

Use a new sterile insulin syringe for each injection and dispose of it safely
The source favors subcutaneous use largely because it bypasses the oral TMAO pathway
Maintenance dosing may require a full 1.0 mL injection at the source concentration
Document dose, timing, site rotation, and perceived energy or training response for consistency
PepTribe is an educational platform. This information is for research and learning purposes only and is not medical advice.
Reference · 02

References

  1. Clinical Pharmacokinetics
    Evans and Fornasini review of L-carnitine pharmacokinetics.
    https://pubmed.ncbi.nlm.nih.gov/14508622/
  2. Clinical Nutrition ESPEN
    Meta-analysis of L-carnitine supplementation and weight loss.
    https://pubmed.ncbi.nlm.nih.gov/31208906/
  3. Molecular Nutrition and Food Research
    Koeth et al. on L-carnitine, TMAO production, and cardiovascular risk discussion.
    https://pubmed.ncbi.nlm.nih.gov/29694978/
  4. American Journal of Kidney Diseases
    Intravenous L-carnitine efficacy and safety in hemodialysis patients.
    https://pubmed.ncbi.nlm.nih.gov/11136175/
  5. CDC
    Subcutaneous injection route guidance.
    https://www.cdc.gov/vaccines/hcp/admin/downloads/YCTS-VaxAdmin-Subcut-injection.pdf
On this page